Sano MC - Search Results

1

Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial.

Kaufmann P, Engelstad K, Wei Y, Jhung S, Sano MC, Shungu DC, Millar WS, Hong X, Gooch CL, Mao X, Pascual JM, Hirano M, Stacpoole PW, DiMauro S, De Vivo DC. Kaufmann P, et al. Among authors: sano mc. Neurology. 2006 Feb 14;66(3):324-30. doi: 10.1212/01.wnl.0000196641.05913.27. Neurology. 2006. PMID: 16476929 Clinical Trial.

2

Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease.

Sano M, Bell K, Cote L, Dooneief G, Lawton A, Legler L, Marder K, Naini A, Stern Y, Mayeux R. Sano M, et al. Arch Neurol. 1992 Nov;49(11):1137-41. doi: 10.1001/archneur.1992.00530350051019. Arch Neurol. 1992. PMID: 1444880 Clinical Trial.

3

Long-term administration of oral physostigmine in Alzheimer's disease.

Stern Y, Sano M, Mayeux R. Stern Y, et al. Neurology. 1988 Dec;38(12):1837-41. doi: 10.1212/wnl.38.12.1837. Neurology. 1988. PMID: 3057398 Clinical Trial.

4

Effects of oral physostigmine in Alzheimer's disease.

Stern Y, Sano M, Mayeux R. Stern Y, et al. Ann Neurol. 1987 Sep;22(3):306-10. doi: 10.1002/ana.410220305. Ann Neurol. 1987. PMID: 3674795 Clinical Trial.

5

Extremely high levels of mutant mtDNAs co-localize with cytochrome c oxidase-negative ragged-red fibers in patients harboring a point mutation at nt 3243.

Petruzzella V, Moraes CT, Sano MC, Bonilla E, DiMauro S, Schon EA. Petruzzella V, et al. Among authors: sano mc. Hum Mol Genet. 1994 Mar;3(3):449-54. doi: 10.1093/hmg/3.3.449. Hum Mol Genet. 1994. PMID: 7912129

6

Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study.

Tatemichi TK, Paik M, Bagiella E, Desmond DW, Stern Y, Sano M, Hauser WA, Mayeux R. Tatemichi TK, et al. Neurology. 1994 Oct;44(10):1885-91. doi: 10.1212/wnl.44.10.1885. Neurology. 1994. PMID: 7936242

7

Clinical determinants of dementia related to stroke.

Tatemichi TK, Desmond DW, Paik M, Figueroa M, Gropen TI, Stern Y, Sano M, Remien R, Williams JB, Mohr JP, et al. Tatemichi TK, et al. Ann Neurol. 1993 Jun;33(6):568-75. doi: 10.1002/ana.410330603. Ann Neurol. 1993. PMID: 8498836

8

Abnormal cranial magnetic resonance imaging scans in sickle-cell disease. Neurological correlates and clinical implications.

Kugler S, Anderson B, Cross D, Sharif Z, Sano M, Haggerty R, Prohovnik I, Hurlet-Jensen A, Hilal S, Mohr JP, et al. Kugler S, et al. Arch Neurol. 1993 Jun;50(6):629-35. doi: 10.1001/archneur.1993.00540060059019. Arch Neurol. 1993. PMID: 8503800

9

A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease.

Thal LJ, Carta A, Clarke WR, Ferris SH, Friedland RP, Petersen RC, Pettegrew JW, Pfeiffer E, Raskind MA, Sano M, Tuszynski MH, Woolson RF. Thal LJ, et al. Neurology. 1996 Sep;47(3):705-11. doi: 10.1212/wnl.47.3.705. Neurology. 1996. PMID: 8797468 Clinical Trial.

10

A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group.

Thal LJ, Schwartz G, Sano M, Weiner M, Knopman D, Harrell L, Bodenheimer S, Rossor M, Philpot M, Schor J, Goldberg A. Thal LJ, et al. Neurology. 1996 Dec;47(6):1389-95. doi: 10.1212/wnl.47.6.1389. Neurology. 1996. PMID: 8960716 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters